Business

Eurofins Generates Record Revenues in H1 2025 and Continues to Improve Its Margins and Cash Generation

LUXEMBOURG, July 23, 2025--Regulatory News: Eurofins (Paris:ERF):

articleEurofins Scientific SeJuly 23, 202543/company/eurofins-scientific-se-1/news/eurofins-generates-record-revenues-in-h1-2025-and-continues-to-improve-its-margins-and-cash-generation-1
Eurofins Generates Record Revenues in H1 2025 and Continues to Improve Its Margins and Cash Generation

About this update from Eurofins Scientific Se

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1518,"height":299,"url":"https://media.zenfs.com/en/business-wire.com/a1540d2ae4d5ec872f65ddf422df9304"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/C1VuyggOoWiT.n0JG_qX.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a1540d2ae4d5ec872f65ddf422df9304","width":960,"height":189},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/0Kmz1WoMqUfcQY3ccua_lA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NzI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a1540d2ae4d5ec872f65ddf422df9304","width":1200,"height":236}},"lazy":false},{"type":"text","content":"LUXEMBOURG, July 23, 2025--(BUSINESS WIRE)--Regulatory News:","length":60,"tagName":"p"},{"type":"text","content":"Eurofins (Paris:ERF):","length":21,"tagName":"p"},{"type":"text","content":"Financial highlights in H1 2025","length":31,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reported revenues of €3,612m increased year-on-year by 5.7% and reached the highest level achieved by Eurofins in any 6-month period in its history.","length":148,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Organic revenue growth13 was 3.9% (2.9% excluding adjustment for public working days).","length":86,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"In what is traditionally the weakest half of the year, adjusted1 EBITDA3 of €810m was 7.0% higher year-on-year vs €757m in H1 2024. The corresponding adjusted EBITDA margin18 of 22.4% and year-on-year improvement of 30bps vs H1 2024 is in line with Eurofins’ public objective to improve its profitability above the level achieved in the prior year.","length":348,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"In the mature scope14 representing €3,361m of revenues (93% of the Group), the adjusted1 EBITDA3 margin was 24.1%, a year-on-year improvement of 70bps and above Eurofins’ FY 2027 target of 24%.","length":193,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The non-mature scope14 (comprising start-ups and acquisitions in significant restructuring) represented revenues of €251m, a sizable increase vs €189m in H1 2024 due to the first-time inclusion of the acqu...

More updates from Eurofins Scientific Se

EurofinsacquisitionsacquisitionsEurofinsreported revenuesacquisitionFree Cash Flow